BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8334068)

  • 1. Intralesional vinblastine in the treatment of oral Kaposi's sarcoma.
    Moyle G; Youle M; Barton S
    Br J Clin Pract; 1993; 47(2):79-80. PubMed ID: 8334068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
    Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
    Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intralesional vinblastine in the treatment of Kaposi's sarcoma. Presentation of a case].
    Gaglioti D; Ficarra G; Nardi P
    Minerva Stomatol; 1989 Sep; 38(9):955-7. PubMed ID: 2811811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
    McCormick SU
    J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
    Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
    Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
    Epstein JB
    Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of conventionally fractionated radiotherapy in the local treatment of HIV-related Kaposi's sarcoma].
    Saran F; Adamietz IA; Mose S; Thilmann C; Böttcher HD
    Strahlenther Onkol; 1995 Oct; 171(10):594-9. PubMed ID: 8571179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Kaposi's lesions in the HIV-infected patient.
    Nichols CM; Flaitz CM; Hicks MJ
    J Am Dent Assoc; 1993 Nov; 124(11):78-84. PubMed ID: 8227776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
    Flaitz CM; Nichols CM; Hicks MJ
    Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caution in the use of local therapies for Kaposi's sarcoma.
    Tappero JW; Berger TG
    Arch Dermatol; 1993 Jan; 129(1):42. PubMed ID: 8420484
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Turiansky G; Wagner KF
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral Kaposi's sarcoma: role of radiotherapy].
    Conill C; Verger E; Ferrer F; Ferré J
    Med Clin (Barc); 1995 Mar; 104(11):436-7. PubMed ID: 7715266
    [No Abstract]   [Full Text] [Related]  

  • 15. Intralesional vinblastine for oral Kaposi sarcoma in HIV infection.
    Epstein JB; Scully C
    Lancet; 1989 Nov; 2(8671):1100-1. PubMed ID: 2572822
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV infection: clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma.
    Epstein JB; Scully C
    Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):38-41. PubMed ID: 1704495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
    Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
    Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
    Zidan J; Robenstein W; Abzah A; Taman S
    Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
    Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
    J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma. Local management with the vinca alkaloids.
    Scott WP
    Coll Works Cardiopulm Dis; 1969 Dec; 15():126-9. PubMed ID: 5382213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.